Erleva 150mg Tablet

产品概览

About Erleva

Erleva is a medication containing the active ingredient Erlotinib, classified as Medication for treatment of non-small-cell lung cancer. Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Erlotinib tablet is a kinase inhibitor indicated for: The treatment of patients with metastatic non-small cell lung cancer.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Erlotinib, the active ingredient in Erleva, belongs to the Medication for treatment of non-small-cell lung cancer class. 1 INDICATIONS AND USAGE Erlotinib tablet is a kinase inhibitor indicated for: The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Erleva. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Erleva for extended periods without medical advice.